CYCLERION THERAPEUTICS, INC. Restricted Cash and Cash Equivalents
CYCLERION THERAPEUTICS, INC. (CYCN) had Restricted Cash and Cash Equivalents of $0 as of 2022-03-31, per its 10-Q filed 2022-05-04.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2022-05-04
- 2022-03-31: Restricted Cash and Cash Equivalents $0.00.
- 2021-12-31: Restricted Cash and Cash Equivalents $0.00.
- 2021-09-30: Restricted Cash and Cash Equivalents $0.00.
- 2021-03-31: Restricted Cash and Cash Equivalents $3.84M.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2022-03-31 | $0.00 10-Q · filed 2022-05-04 |
| 2021-12-31 | $0.00 10-K · filed 2022-02-24 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 |
| 2021-03-31 | $3.84M 10-Q · filed 2022-05-04 |
| 2020-12-31 | $3.84M 10-K · filed 2022-02-24 |
| 2020-09-30 | $3.84M 10-Q · filed 2021-11-09 |
| 2020-06-30 | $4.99M 10-Q · filed 2021-07-29 |
| 2020-03-31 | $4.99M 10-Q · filed 2021-04-30 |
| 2019-12-31 | $7.73M 10-K · filed 2021-02-25 |
| 2019-09-30 | $7.73M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $7.73M 10-Q · filed 2020-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |